Webinar: Strengthening patient involvement in Health Technology Assessment (HTA)

image_pdfSave as PDFimage_printPrint this page

Note: This webinar took place on Monday 28 September 2015. You can find a video recording and the presentation used during the webinar below.

Webinar introduction

HTA is a multidisciplinary process that examines the information about medical, cost-effectiveness, social, political, legal and ethical considerations of the application of a health technology – usually a medicine, medical device or clinical/surgical procedure. The main purpose of conducting an assessment is to inform policy decision making, which has an impact on patients and their ecosystem of health, including physicians and payers.

The webinar will examine the need for patient involvement in HTA and look at the HTA landscape in Europe. A patient organisation representative will present a case study on patient participation in HTA, and the conversation will also look at how the EUPATI toolkit can help informed patients engage in HTA.

Webinar agenda

TimeAgenda
17.00Welcome and introductions
Daphnee Pushparajah, UCB
17.10HTA Introduction?”
Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Grouper
17.25“Good practices in patient involvement in HTA. Are they being used?”
Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Grouper
17.40“Patients’ voice in access decisions. A discussion of the roles patients can play.”
Nick Meade, Director of Policy, Genetic Alliance UK
18.05Q & A – Panel members: All presenters
18.30Close of the Webinar

Webinar recording

Click here to view WebEx version here (Quality slightly better!).

Download HTA Infographic

Click here to download

Webinar presentations

 

Presentation 1: Good practices in patient involvement in HTA. Are they being used?

Speaker: Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Group


Download PDF of presentation

 

Presentation 2: Patients’ voice in access decisions. A discussion of the roles patients can play.

Speaker: Nick Meade, Director of Policy, Genetic Alliance UK


Download PDF of presentation

 

Presentation 3: Health Technology Assessment.


Download PDF of presentation

 

Back to top

Search Toolbox

Find Out More